D. Zelterman

R. Herbst, A. Chiang, D. Zelterman, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Vesicular Stomatitis Virus-Based Therapeutic Vaccination Targeted to the E1, E2, E6, and E7 Proteins of Cottontail Rabbit Papillomavirus

D. Zelterman, A. Roberts, J. Rose, 2007, Journal of Virology.

Functional activity of murine CD34+ and CD34- hematopoietic stem cell populations.

D. Zelterman, D. Krause, S. Sharkis, 1999, Experimental hematology.

Ontogenesis of spontaneous activity and habituation of activity in the rat pup.

B. Shaywitz, D. Zelterman, J. Gordon, 1979, Developmental psychobiology.

Pruritic and nociceptive sensations and dysesthesias from a spicule of cowhage.

R H LaMotte, R. LaMotte, S. G. Shimada, 2009, Journal of neurophysiology.

Natural ventilation reduces high TB transmission risk in traditional homes in rural KwaZulu-Natal, South Africa

D. Zelterman, G. Friedland, Yanhong Deng, 2013, BMC Infectious Diseases.

Fructosamine reference ranges in rhesus macaques (Macaca mulatta).

Misty J. Williams-Fritze, D. Zelterman, Peter C. Smith, 2011, Journal of the American Association for Laboratory Animal Science : JAALAS.

Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy

L. Harris, D. Zelterman, C. Hatzis, 2015, Breast Cancer Research and Treatment.

P3.02c-048 A Phase I/II Trial Evaluating the Combination of Stereotactic Body Radiotherapy and Pembrolizumab in Metastatic NSCLC: Topic: IT

R. Herbst, A. Chiang, D. Zelterman, 2017 .

Comparison of MRI Outcomes of Uterine Artery Embolization for Uterine Leiomyoma Using Tris-acryl Gelatin Microspheres, Polyvinyl Alcohol Spheres, and Polyvinyl Alcohol Particles

Jorge A. Gálvez, Robert I. White, D. Zelterman, 2008, Journal of computer assisted tomography.

Testing violations of the exponential assumption in cancer clinical trials with survival endpoints

L. Pusztai, Heping Zhang, D. Zelterman, 2017, Biometrics.

Peripheral blood progenitor cell cycle kinetics following priming with pIXY321 in patients treated with the "ICE" regimen.

D. Zelterman, S. Lutzker, A. Gollerkeri, 1998, The Yale journal of biology and medicine.

variant is a biomarker of poor outcome, platinum resistance and a potential target for therapy in ovarian cancer.

Linda, Trupti, F. Slack, 2016 .

Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States

D. Zelterman, G. Garcia-Manero, D. Steensma, 2017, Transfusion.

Regression methods for the appearances of extremes in climate data

D. Zelterman, M. Kane, Wei Wei, 2022, Environmetrics.

Total Parenteral Nutrition induced Liver Pathology: An Autopsy Series of 24 Newborn Cases

R. Ehrenkranz, D. Zelterman, E. Zambrano, 2004, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer.

D. Zelterman, S. Anderson, Y. Cheng, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Granulocyte-Macrophage Colony-Stimulating Factor Priming plus Papillomavirus E6 DNA Vaccination: Effects on Papilloma Formation and Regression in the Cottontail Rabbit Papillomavirus-Rabbit Model

D. Zelterman, S. Leachman, M. Slade, 2000, Journal of Virology.

Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantation

Tae Kon Kim, D. Zelterman, A. Zeidan, 2018, Annals of Hematology.

Tuberculosis in physicians: compliance with surveillance and treatment.

D. Zelterman, W. Lohman, S. Kirkhorn, 1996, American journal of infection control.

Homogeneity of the relative risk in cohort studies.

C. Le, B. Lindgren, D. Zelterman, 1991, Statistics in medicine.

Clinical Trial Design Using A Stopped Negative Binomial Distribution.

D. Zelterman, M. Kane, M. Deveaux, 2018, Statistics and its interface.

Clinical and Serologic Responses After a Two‐dose Series of High‐dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single‐arm Trial

M. Dhodapkar, D. Zelterman, R. Albrecht, 2017, Clinical Lymphoma, Myeloma & Leukemia.

Phase I Dose Escalation Trial of Weekly Docetaxel Plus Irinotecan in Patients with Advanced Cancer

D. Zelterman, A. Argiris, B. Burtness, 2002, Cancer biology & therapy.

The Use of Hypomethylating Agents (HMAs) in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML): Clinical Outcomes and Their Predictors in a Large International Patient Cohort

Tae Kon Kim, D. Zelterman, P. Fenaux, 2016 .

Bayesian local exchangeability design for phase II basket trials

D. Zelterman, Yilin Liu, M. Kane, 2021, Statistics in medicine.

Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.

L. Wilson, D. Zelterman, F. Detterbeck, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metachronous Primary Melanoma and Lymphoma

S. Ariyan, D. Zelterman, D. Narayan, 2010, Annals of plastic surgery.

Early Biochemical Events in Pneumococcal Otitis Media: Arachidonic Acid Metabolites in Middle Ear Fluid

D. Zelterman, S. Juhn, G. Giebink, 1991, The Annals of otology, rhinology, and laryngology.

The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.

R. Crystal, D. Zelterman, A. Deisseroth, 2001, Cancer research.

Inadequate Treatment of Depressed Nursing Home Elderly

R. Kane, D. Zelterman, L. Heston, 1992, Journal of the American Geriatrics Society.

Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia

B. Smith, D. Zelterman, W. Holmes, 1999, Bone Marrow Transplantation.

Causality: Models, Reasoning, and Inference

D. Zelterman, 2001, Technometrics.

Contingency Tables in Medical Studies

Thomas A. Louis, Daniel Zelterman, T. Louis, 2019, Medical Uses of Statistics.

WAG‐F8m1Ycb rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A

D. Zelterman, S. Compton, C. Booth, 2010, Journal of thrombosis and haemostasis : JTH.

Sums of dependent Bernoulli random variables and disease clustering

Daniel Zelterman, D. Zelterman, Chang Yu, 2002 .

Applied Multivariate Statistics with R

Daniel Zelterman, D. Zelterman, 2015, Statistics for Biology and Health.

Applied Linear Models with SAS

D. Zelterman, 2010 .

Applied Linear Models with SAS: Contents

D. Zelterman, 2010 .

Beta prime regression with application to risky behavior frequency screening

D. Zelterman, A. Tulupyev, A. Suvorova, 2013, Statistics in medicine.

The maximum negative binomial distribution

Zhongxing Zhang, D. Zelterman, B. Burtness, 2000 .

Models for Discrete Data

Daniel Zelterman, D. Zelterman, 1999 .

The Maximum Negative Hypergeometric Distribution

D. Zelterman, 2005, 1802.09673.

Ubiquitin-Fused and/or Multiple Early Genes from Cottontail Rabbit Papillomavirus as DNA Vaccines

D. Zelterman, S. Leachman, M. Slade, 2002, Journal of Virology.

Topical CTC-96 accelerates wart growth in rabbits infected with cottontail rabbit papillomavirus.

D. Zelterman, S. Coughlin, R. Mcglennen, 1994, Antiviral research.

DNA polymerase beta is critical for genomic stability of sperm cells.

D. Zelterman, J. Sweasy, S. Dalal, 2011, DNA repair.

Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity.

D. Zelterman, Yuri Kim, Q. Lin, 2009, Cancer research.

Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis

D. Zelterman, A. Bothwell, O. Henegariu, 2010, Proceedings of the National Academy of Sciences.

Mutation of A DNA Repair Enzyme Causes Lupus in Mice

C. Zeiss, D. Zelterman, J. Sweasy, 2016 .

Mutation of POLB causes lupus in mice.

C. Zeiss, D. Zelterman, J. Sweasy, 2014, Cell reports.

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

N. Schultz, M. Ladanyi, D. Zelterman, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors

D. Zelterman, K. Politi, W. Lockwood, 2018, Journal of Immunotherapy for Cancer.

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

R. Herbst, D. Zelterman, D. Rimm, 2018, Nature Communications.

Treatment of childhood acute lymphoblastic leukemia at a regional non-academic center in Belarus.

D. Zelterman, J. van Hoff, Sergey P Chunikhovskiy, 2002, Medical and pediatric oncology.

A spatial simulation approach to account for protein structure when identifying non-random somatic mutations

Kei-Hoi Cheung, Hongyu Zhao, Gregory A. Ryslik, 2013, BMC Bioinformatics.

DNA polymerase β is critical for mouse meiotic synapsis

Daniel Zelterman, Scott Keeney, S. Keeney, 2010, The EMBO journal.

Should the 7th Edition of the Lung Cancer Stage Classification System Change Treatment Algorithms in Non-small Cell Lung Cancer?

J. Crowley, R. Rami-Porta, L. Tanoue, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA

Abhijit A. Patel, S. Mane, N. Carriero, 2018, Clinical Cancer Research.

A 3 ' UTR KRAS-variant as a biomarker of poor outcome and platinum chemotherapy resistance in ovarian cancer

Joanne, F. Slack, D. Katsaros, 2017 .

A KRAS-variant is a Biomarker of Poor Outcome, Platinum Chemotherapy Resistance and a Potential Target for Therapy in Ovarian Cancer

F. Slack, J. Weidhaas, D. Katsaros, 2011, Oncogene.

The incidence and risk factors associated with postoperative delirium in geriatric patients undergoing surgery for suspected gynecologic malignancies.

J. McAlpine, D. Zelterman, M. Kelly, 2008, Gynecologic oncology.

Distributions associated with simultaneous multiple hypothesis testing

D. Zelterman, Chang Yu, 2018, 1802.09018.

16 A semiparametric bootstrap for simulating extreme order statistics

Robert L. Strawderman, Daniel Zelterman, R. Strawderman, 1998, Order statistics.

The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma

D. Zelterman, S. Gettinger, K. Politi, 2019, Clinical Cancer Research.

Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer.

D. Zelterman, M. Mckneally, J. Bennett, 1983, Cancer research.

Escaping the stem cell compartment: Sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations

D. Zelterman, D. Brash, É. Remenyik, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential

D. Katsaros, D. Zelterman, R. Singal, 2006, Cancer.

Application of Technology: Managing Attribute-Value Clinical Trials Data Using the ACT/DB Client-Server Database System

Perry L. Miller, Cynthia Brandt, Prakash M. Nadkarni, 1998, J. Am. Medical Informatics Assoc..

Exact Tests of Significance in Higher Dimensional Tables

D. Zelterman, P. Mielke, I. S. Chan, 1995 .

Pregnancy and birth rates among HIV-infected women in the United States: the confounding effects of illicit drug use

K. Katz, D. Zelterman, B. Forsyth, 2002, AIDS.

A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis.

David Tuck, Daniel Zelterman, Nicola Miller, 2011, The Lancet. Oncology.

A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk.

F. Slack, J. Weidhaas, Lena J. Chin, 2010, Cancer research.

Discrete Distributions: Applications in the Health Sciences

D. Zelterman, 2004 .

Impact of structural ageism on greater violence against older persons: a cross-national study of 56 countries

D. Zelterman, B. Levy, E. Chang, 2021, BMJ Open.

Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.

L. Wilson, D. Ross, D. Zelterman, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Methylation of Twelve CpGs in Human Papillomavirus Type 16 (HPV16) as an Informative Biomarker for the Triage of Women Positive for HPV16 Infection

P. Lizardi, D. Zelterman, M. Harigopal, 2014, Cancer Prevention Research.

DNA polymerase beta participates in DNA End-joining

Gregory A. Breuer, D. Zelterman, J. Sweasy, 2017, Nucleic acids research.

Rare BRCA1 haplotypes including 3’UTR SNPs associated with breast cancer risk

F. Slack, K. Kidd, A. Hollestelle, 2011, Cell cycle.

Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma

D. Zelterman, D. Rimm, H. Kluger, 2019, Journal of Immunotherapy for Cancer.

Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma

Daniel Zelterman, David L. Rimm, Balazs Acs, 2019, Clinical Cancer Research.

Modeling Survival Data: Extending the Cox Model

Daniel Zelterman, Haiqun Lin, Haiqun Lin, 2002, Technometrics.

Atrial Fibrillation After Cardiac Surgery/Cardiopulmonary Bypass Is Associated with Monocyte Activation

B. Smith, D. Zelterman, J. Mathew, 2005, Anesthesia and analgesia.

The Use of theL-Plastin Promoter for Adenoviral-mediated , Tumor-specific Gene Expression in Ovarian and Bladder Cancer Cell Lines 1

R. Crystal, D. Zelterman, A. Deisseroth, 2001 .

AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers

E. Petricoin, L. Liotta, D. Zelterman, 2023, npj Precision Oncology.

Abstract P5-13-02: Neoadjuvant aromatase inhibitor therapy plus the mTOR inhibitor everolimus in postmenopausal women with hormone receptor positive/HER2 negative breast cancer and an oncotype Dx recurrence score (≤25)

D. Zelterman, C. Hatzis, G. Chung, 2020 .

Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma

S. Ariyan, D. Zelterman, A. Buzaid, 1999, Cancer.

CDK 4/6 drug target activation mapping of HR+/HER2- metastatic breast cancer for treatment selection and response prediction.

E. Petricoin, D. Zelterman, C. Hatzis, 2020 .

D. Zelterman, M. Paparella, D Zelterman, 1991, Archives of otolaryngology--head & neck surgery.

MethylationofTwelveCpGsinHumanPapillomavirusType16 (HPV16)asanInformativeBiomarkerfortheTriageofWomen Positive for HPV16 Infection

P. Lizardi, D. Zelterman, M. Harigopal, 2014 .

MethylationofTwelveCpGs inHumanPapillomavirusType 16 ( HPV 16 ) as an Informative Biomarker for the Triage ofWomen Positive for HPV 16 Infection

Ying Sun, P. Lizardi, D. Zelterman, 2014 .

Positive for HPV 16 Infection ( HPV 16 ) as an Informative Biomarker for the Triage of Women Methylation of Twelve CpGs in Human Papillomavirus Type 16

Ying Sun, P. Lizardi, D. Zelterman, 2014 .

Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients.

D. Zelterman, E. Salloum, D Zelterman, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy.

P. Lizardi, D. Zelterman, M. Harigopal, 2009, Virology.

Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial

Winnie S. Liang, N. Schork, E. Petricoin, 2021, PloS one.

Prevalence of carotid canal dehiscence in the human middle ear: A report of 1000 temporal bones

D. Zelterman, M. Paparella, M. Goycoolea, 1994, The Laryngoscope.

Middle Ear Fluid Lysozyme Source in Experimental Pneumococcal Otitis Media

D. Zelterman, S. Juhn, T. Harada, 1991, The Annals of otology, rhinology, and laryngology.

Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen

B. Shaywitz, S. Shaywitz, D. Zelterman, 2003, Menopause.

Reversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors.

D. Zelterman, J. Rose, L. Buonocore, 2010, Vaccine.

A Stopped Negative Binomial Distribution

D. Zelterman, M. Kane, M. Deveaux, 2015, 1508.01264.

Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin–bound paclitaxel in patients with advanced solid tumors

L. Harris, D. Zelterman, S. Gettinger, 2015, Cancer.

The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer

Xifeng Wu, J. Weidhaas, H. Heneghan, 2012, PloS one.

Association between KRAS rs61764370 and triple-negative breast cancer—a false positive? – Authors' reply

F. Slack, J. Weidhaas, H. Heneghan, 2011 .

Diagnostics for the Accelerated Life Time Model of Survival Data

Daniel Zelterman, Haiqun Lin, Haiqun Lin, 2003, Advances in Survival Analysis.

Rank tests of association for exchangeable paired data

Daniel Zelterman, D. Zelterman, Ju Li, 2002 .

Bootstrap techniques for proportional hazards models with censored observations

Thomas A. Louis, Daniel Zelterman, Chap T. Le, 1996, Stat. Comput..

A randomized controlled trial of meditation and massage effects on quality of life in people with late-stage disease: a pilot study.

D. Zelterman, P. Selwyn, V. Njike, 2005, Journal of palliative medicine.

The effect of 6-hydroxydopamine on habituation of activity in the developing rat pup

B. Shaywitz, D. Zelterman, J. H. Klopper, 1977, Pharmacology Biochemistry and Behavior.

Unified exact design with early stopping rules for single arm clinical trials with multiple endpoints

Daniel Zelterman, Denise Esserman, Michael Kane, 2021, Statistical methods in medical research.

Evaluation of irinotecan plus paclitaxel in patients with advanced non-small cell lung cancer

D. Zelterman, M. Rose, A. Rosenfield, 2005, Cancer biology & therapy.

Reproductive Function After Conservative Surgery and Chemotherapy for Malignant Germ Cell Tumors of the Ovary

D. Zelterman, P. Schwartz, J. Tangir, 2003, Obstetrics and gynecology.

Statistical design for a small serial dilution series

Daniel Zelterman, Alexander Tulupyev, Robert Heimer, 2010, Statistics in medicine.

Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations.

R. Kane, D. Zelterman, L. Heston, 1991, JAMA.

Geographic poverty and racial/ethnic disparities in cervical cancer precursor rates in Connecticut, 2008-2009.

J. Hadler, D. Zelterman, J. Meek, 2013, American journal of public health.

Goodness of Fit Tests for Proportional Hazards Regression Models

C. Le, D. Zelterman, 1992 .

Postoperative Vaginal Cuff Brachytherapy Alone (VB) Provides Equally Effective Treatment with Less Toxicity Than External Beam Radiation and Vaginal Cuff Brachytherapy (EXT + VB) in the Treatment of Stage II Endometrial Adenocarcinoma

D. Zelterman, E. Ratner, T. Rutherford, 2010 .

Univariate Normal Distribution

D. Zelterman, 2020, Definitions.

Other Useful Methods

D. Zelterman, 2015 .

DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin Therapy

D. Zelterman, P. Glazer, J. Sweasy, 2017, Molecular Cancer Research.

An occupancy distribution arising in a limiting dilution assay for HIV-1

D. Zelterman, 2006 .

Five-Year Update of an Expanded Phase II Study of Dose-Dense and -Intense Doxorubicin, Paclitaxel and Cyclophosphamide (ATC) in High-Risk Breast Cancer

M. Reiss, D. Zelterman, G. Chung, 2005, Oncology.

A statistical distribution with an unbounded hazard function and its application to a theory from demography.

D. Zelterman, 1992, Biometrics.

Indicator models in social mobility tables

D. Zelterman, Ted I. K. Youn, 1992 .

Human POLB Gene Is Mutated in High Percentage of Colorectal Tumors*

Daniel Zelterman, Xiangyu Cong, D. Zelterman, 2012, The Journal of Biological Chemistry.

Applied Linear Models with SAS: Review of Methods

Daniel Zelterman, D. Zelterman, 2010 .

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

R. Herbst, D. Zelterman, D. Rimm, 2018, Nature Communications.

Longitudinal study of psychotropic drug use by elderly nursing home residents.

R. Kane, D. Zelterman, L. Heston, 1992, Journal of gerontology.

Accounting for Multiple Comparisons in Statistical Analysis of the Extensive Bioassay Data on Glyphosate.

E. Crouch, J. Haseman, D. Zelterman, 2020, Toxicological sciences : an official journal of the Society of Toxicology.

The effects of school-based health clinics in St. Paul on school-wide birthrates.

D. Zelterman, S. Potthoff, M. Resnick, 1993, Family planning perspectives.

Impact of immediate postoperative death on the estimation of a survival benefit from postoperative radiation therapy for cancer of the gallbladder.

D. Zelterman, J. Knisely, R. Decker, 2008, Journal of Clinical Oncology.

Patterns of response to acute naloxone infusion in Tourette's syndrome

J. Leckman, D. Zelterman, L. Scahill, 2000, Movement disorders : official journal of the Movement Disorder Society.

Discrete distributions for use in twin studies.

L. Waller, D. Zelterman, C. Yu, 1998, Biometrics.

Multivariate Discrete Models for Longevity in Twins

D. Zelterman, Chang Yu, 1999 .

Testing for central mixtures of compartment model parameters.

D. Zelterman, 1989, Statistics in medicine.

Survival from XDR-TB Is Associated with Modifiable Clinical Characteristics in Rural South Africa

D. Zelterman, F. Altice, G. Friedland, 2012, PloS one.

MA15.06 Predictive Value of Measuring Somatic Mutations and Tumor Infiltrating Lymphocytes for PD-1 Axis Therapy in Non-Small Cell Lung Cancer (NSCLC)

R. Herbst, D. Zelterman, D. Rimm, 2017 .

On tests for qualitative interactions

Daniel Zelterman, D. Zelterman, 1990 .

Differential outcomes in patients with uncommon EGFR exon 19 mutations.

D. Zelterman, S. Gettinger, K. Politi, 2018 .

The log-likelihood ratio for sparse multinomial mixtures

D. Zelterman, 1986 .

Statistical Inference for Familial Disease Clusters

Daniel Zelterman, D. Zelterman, Chang Yu, 2002, Biometrics.

EXACT INFERENCE FOR FAMILY DISEASE CLUSTERS

D. Zelterman, Chang Yu, 2001 .

Sums of exchangeable Bernoulli random variables for family and litter frequency data

Chang Yu, Daniel Zelterman, D. Zelterman, 2008, Comput. Stat. Data Anal..

Patient-Reported Outcomes and Cosmesis in a Feasibility Study of 4-Dimensional Simulated Image Guided Accelerated Partial Breast Irradiation.

L. Wilson, J. Weidhaas, D. Zelterman, 2019, Practical radiation oncology.

Analyzing Multiply Matched Cohort Studies with Two Different Comparison Groups: Application to Pregnancy Rates among HIV+ Women

D. Zelterman, B. Forsyth, Yan Li, 2003, Biometrics.

Multivariate Normal Distribution

D. Zelterman, 2015 .

A parametric model to estimate the proportion from true null using a distribution for p-values

Chang Yu, Daniel Zelterman, D. Zelterman, 2017, Comput. Stat. Data Anal..

Implicit and Explicit Dehumanization of Older Family Members: Novel Determinants of Elder Abuse Proclivity.

D. Zelterman, B. Levy, E. Chang, 2022, Stigma and Health.

Robust estimation in truncated discrete distributions with application to capture-recapture experiments

Daniel Zelterman, D. Zelterman, 1988 .

A two‐stage phase II clinical trial design with nested criteria for early stopping and efficacy

D. Zelterman, M. Kane, M. Deveaux, 2019, Pharmaceutical statistics.

Homogeneity Tests against Central-Mixture Alternatives

Daniel Zelterman, D. Zelterman, Chan‐Fu Chen, 1988 .

Causality: Models, Reasoning, and Inference

Daniel Zelterman, D. Zelterman, 2001, Technometrics.

Approximating the distribution of goodness of fit tests for discrete data

D. Zelterman, 1984 .

Likelihood ratio tests for central mixtures

D. Zelterman, 1988 .

Evaluation of Staging Systems for Colorectal Cancer

P. Grambsch, C. Le, B. Lindgren, 1993 .

Applied Linear Models with SAS: Review of Methods

D. Zelterman, 2010 .

Impact of Structural Ageism on Greater Violence Against Older Persons: A Cross-National Study of 56 Countries

D. Zelterman, B. Levy, E. Chang, 2021, Innovation in Aging.

Application of Technology: Managing Attribute-Value Clinical Trials Data Using the ACT/DB Client-Server Database System

C. Brandt, D. Zelterman, P. Nadkarni, 1998, J. Am. Medical Informatics Assoc..

ACT/DB: A Clinical Trials Database Being Refined on a Pilot Basis at Two Medical Centers

Perry L. Miller, Cynthia Brandt, Prakash M. Nadkarni, 1998, AMIA.

Log-linear modeling with the negative multinomial distribution.

L A Waller, L. Waller, D. Zelterman, 1997, Biometrics.

Reversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors.

D. Zelterman, J. Rose, L. Buonocore, 2010, Vaccine.